<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03100474</url>
  </required_header>
  <id_info>
    <org_study_id>ND001</org_study_id>
    <nct_id>NCT03100474</nct_id>
  </id_info>
  <brief_title>Global Registry: ExAblate Neuro MR Guided Focused Ultrasound (MRgFUS) of Neurological Disorders:</brief_title>
  <official_title>Global Registry: ExAblate 4000 Transcranial MR Guided Focused Ultrasound (TcMRgFUS) of Neurological Disorders:</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>InSightec</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>InSightec</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A global post approval study to collect safety and effectiveness data related to ExAblate
      Neuro for the treatment of certain disorders such as Essential Tremor, Parkinson's Movement
      Disorders, or Neuropathic Pain within the thalamus and/or pallidum.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A global, multi-center, open-label, observational registry to capture safety and
      effectiveness data related to ExAblate Neuro, an MRI guided focused ultrasound device
      designed to lesion tissue deep within the brain using sound waves without the need for
      craniotomy. This registry includes certain regional and country specific approved thalamotomy
      and pallidotomy procedures using ExAblate Neuro for the treatment of various neurologic
      disorders such as essential tremor, Parkinson's movement disorders, and neuropathic pain.
      Treatment targets/indications are country/region dependent based on approved labeling within
      that region.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2016</start_date>
  <completion_date type="Anticipated">January 2024</completion_date>
  <primary_completion_date type="Anticipated">January 2020</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>5 Years</target_duration>
  <primary_outcome>
    <measure>Clinical Rating Scale for Tremor</measure>
    <time_frame>5 year</time_frame>
    <description>CRST</description>
  </primary_outcome>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Essential Tremor</condition>
  <condition>Parkinson's Disease</condition>
  <condition>Movement Disorders</condition>
  <condition>Neuropathic Pain</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Any patients suffering from clinically diagnosed neurologic disorders that can be
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Meets labeling indication for use per information for prescribers

          -  Target is accessible by Focused Ultrasound per treatment planning parameters

        Exclusion Criteria:

          -  Do not agree to participate or who are unlikely to participate over an extended period
             of time
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Howard Eisenberg, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Maryland</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Project Manager</last_name>
    <phone>1-214-630-2000</phone>
  </overall_contact>
  <location>
    <facility>
      <name>Rambam Healthcare Campus</name>
      <address>
        <city>Haifa</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alon Sinai, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Menashe Zaaroor, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sheba Medical Center</name>
      <address>
        <city>Ramat Gan</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ayelet Brill</last_name>
    </contact>
    <investigator>
      <last_name>Simon Israeli-Korn, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 29, 2017</study_first_submitted>
  <study_first_submitted_qc>April 3, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 4, 2017</study_first_posted>
  <last_update_submitted>May 22, 2018</last_update_submitted>
  <last_update_submitted_qc>May 22, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 24, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>tremor</keyword>
  <keyword>Parkinson's</keyword>
  <keyword>movement</keyword>
  <keyword>neuropathic</keyword>
  <keyword>pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease</mesh_term>
    <mesh_term>Parkinson Disease</mesh_term>
    <mesh_term>Neuralgia</mesh_term>
    <mesh_term>Tremor</mesh_term>
    <mesh_term>Movement Disorders</mesh_term>
    <mesh_term>Essential Tremor</mesh_term>
    <mesh_term>Nervous System Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>Data will be shared via request from the publication committee. Active site participants will have access; however, it has not been decided when or if data will be shared with researchers not participating on this registry.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

